A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Brain Irradiation and Tremelimumab in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Adjuvant Durvalumab for Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can...
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE2
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3